Clinical Trial Update: FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This Phase 2 study investigates high-low mixed-dose radiotherapy combined with chemo-immunotherapy induction for locally advanced non-small cell lung cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fudan University | Conditions: NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 2 | Status: NOT_YET_RECRUITING